Back to User profile » Dr Marjaana Koponen

Papers published by Dr Marjaana Koponen:


Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders

Tsai DHT, Bell JS, Abtahi S, Baak BN, Bazelier MT, Brauer R, Chan AYL, Chan EW, Chen H, Chui CSL, Cook S, Crystal S, Gandhi P, Hartikainen S, Ho FK, Hsu ST, Ilomäki J, Kim JH, Klungel OH, Koponen M, Lau WCY, Lau KK, Lum TYS, Luo H, Man KKC, Pell JP, Setoguchi S, Shao SC, Shen CY, Shin JY, Souverein PC, Tolppanen AM, Wei L, Wong ICK, Lai ECC

Clinical Epidemiology 2023, 15:1241-1252

Published Date: 21 December 2023

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study

Paakinaho A, Tiihonen M, Koskela H, Koponen M, Tiihonen J, Hartikainen S, Tolppanen AM

Clinical Epidemiology 2023, 15:695-705

Published Date: 12 June 2023

Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study

Koponen M, Paakinaho A, Lin J, Hartikainen S, Tolppanen AM

Clinical Epidemiology 2022, 14:1217-1227

Published Date: 27 October 2022

Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer’s Disease

Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM

Clinical Epidemiology 2021, 13:295-307

Published Date: 22 April 2021

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons

Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S

Clinical Epidemiology 2016, 8:363-371

Published Date: 11 October 2016